Role of apolipoprotein C‐III overproduction in diabetic dyslipidaemia
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of apolipoprotein C‐III overproduction in diabetic dyslipidaemia
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-04-12
DOI
10.1111/dom.13744
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- APOC3Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular RiskHighlights
- (2018) Anders B. Wulff et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes
- (2018) Marco Colombo et al. ATHEROSCLEROSIS
- Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
- (2018) Daniel J. Drucker Cell Metabolism
- APOC-III Antisense Oligonucleotides: A New Option for the Treatment of Hypertriglyceridemia
- (2018) Joel Schmitz et al. CURRENT MEDICINAL CHEMISTRY
- Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism
- (2018) Bastian Ramms et al. CURRENT OPINION IN LIPIDOLOGY
- Effect of statin therapy on plasma apolipoprotein CIII concentrations: A systematic review and meta-analysis of randomized controlled trials
- (2018) Amirhossein Sahebkar et al. Journal of Clinical Lipidology
- Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease
- (2018) Anum Saeed et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Liraglutide treatment improves postprandial lipid metabolism and cardiometabolic risk factors in humans with adequately controlled type 2 diabetes: A single-centre randomized controlled study
- (2018) Niina Matikainen et al. DIABETES OBESITY & METABOLISM
- Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity
- (2017) M.-R. Taskinen et al. JOURNAL OF INTERNAL MEDICINE
- Apolipoprotein C-III inhibits triglyceride hydrolysis by GPIHBP1-bound LPL
- (2017) Mikael Larsson et al. JOURNAL OF LIPID RESEARCH
- High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts
- (2017) Majken K. Jensen et al. CIRCULATION
- Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions
- (2017) Meenakshi Sundaram et al. JOURNAL OF LIPID RESEARCH
- Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
- (2016) Marja-Riitta Taskinen et al. Current Atherosclerosis Reports
- ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
- (2016) Philip L.S.M. Gordts et al. JOURNAL OF CLINICAL INVESTIGATION
- Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal ObesitySignificance
- (2015) Jan Borén et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Plasma Apolipoprotein C-III Levels, Triglycerides, and Coronary Artery Calcification in Type 2 DiabeticsSignificance
- (2015) Arman Qamar et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Lipoprotein effects of incretin analogs and dipeptidyl peptidase 4 inhibitors
- (2015) Jixin Zhong et al. Clinical Lipidology
- The crucial roles of apolipoproteins E and C-III in apoB lipoprotein metabolism in normolipidemia and hypertriglyceridemia
- (2015) Frank M. Sacks CURRENT OPINION IN LIPIDOLOGY
- The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis
- (2015) Moritz C. Wyler von Ballmoos et al. Journal of Clinical Lipidology
- Apolipoprotein C-III: From Pathophysiology to Pharmacology
- (2015) Giuseppe Danilo Norata et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Apolipoprotein C-III
- (2015) Alison B. Kohan Current Opinion in Endocrinology Diabetes and Obesity
- GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
- (2014) Charles Pyke et al. ENDOCRINOLOGY
- Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
- (2014) Anders Berg Jørgensen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting APOC3 in the Familial Chylomicronemia Syndrome
- (2014) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Hepatic lipogenesis and a marker of hepatic lipid oxidation, predict postprandial responses of triglyceride-rich lipoproteins
- (2014) Niina Matikainen et al. Obesity
- Relative Quantitation of Glycoisoforms of Intact Apolipoprotein C3 in Human Plasma by Liquid Chromatography–High-Resolution Mass Spectrometry
- (2013) Wenying Jian et al. ANALYTICAL CHEMISTRY
- Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
- (2013) Mark J. Graham et al. CIRCULATION RESEARCH
- The revised Lund-Malmö GFR estimating equation outperforms MDRD and CKD-EPI across GFR, age and BMI intervals in a large Swedish population
- (2013) Ulf Nyman et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial
- (2013) K. Hermansen et al. DIABETES OBESITY & METABOLISM
- Epicardial Fat, Cardiac Dimensions, and Low-Grade Inflammation in Young Adult Monozygotic Twins Discordant for Obesity
- (2012) Marit Granér et al. AMERICAN JOURNAL OF CARDIOLOGY
- Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production
- (2012) Zemin Yao et al. CURRENT OPINION IN LIPIDOLOGY
- Dual Metabolic Defects Are Required to Produce Hypertriglyceridemia in Obese Subjects
- (2011) Marja-Riitta Taskinen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Remnant Lipoproteins As Strong Key Particles to Atherogenesis
- (2011) Yoshio Fujioka et al. Journal of Atherosclerosis and Thrombosis
- Plasma apolipoprotein C-III metabolism in patients with chronic kidney disease
- (2011) Esther M. M. Ooi et al. JOURNAL OF LIPID RESEARCH
- Complexities of plasma apolipoprotein C-III metabolism: Fig. 1.
- (2011) Frank M. Sacks et al. JOURNAL OF LIPID RESEARCH
- Transcriptional Activation of Apolipoprotein CIII Expression by Glucose May Contribute to Diabetic Dyslipidemia
- (2010) Sandrine Caron et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Long-TE 1H MRS suggests that liver fat is more saturated than subcutaneous and visceral fat
- (2010) Jesper Lundbom et al. NMR IN BIOMEDICINE
- Metabolism of Very-Low-Density Lipoprotein and Low-Density Lipoprotein Containing Apolipoprotein C-III and Not Other Small Apolipoproteins
- (2009) Carlos O. Mendivil et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan
- (2009) A. Hiukka et al. DIABETES
- Triglyceride-Rich Lipoprotein-Associated Apolipoprotein C-III Production Is Stimulated by Plasma Free Fatty Acids in Humans
- (2008) Mirjana Pavlic et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
- (2008) Esther M. M. Ooi et al. CLINICAL SCIENCE
- Dose-Dependent Effect of Rosuvastatin on VLDL-Apolipoprotein C-III Kinetics in the Metabolic Syndrome
- (2008) E. M.M. Ooi et al. DIABETES CARE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started